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Edited by Jesus AvilaAbstract The strong pH dependence of Ab oligomerization
could arise from favorable intermolecular charge–charge interac-
tions between His and carboxylate groups, or, alternatively, by
mutual electrostatic repulsion of peptide molecules. To test be-
tween these two possibilities, the pH dependence of the oligomer-
ization of Ab and three charge substitution variants with Asp,
Glu and His substituted by Ala is measured. All four peptides oli-
gomerize, as detected by thioﬂavin T ﬂuorescence, turbidity, and
amyloid ﬁbril formation; therefore, speciﬁc charge–charge inter-
actions are nonessential for oligomerization. The strong negative
correlation between net charge and oligomerization indicates
that electrostatic repulsion between Ab monomers impedes their
association.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Several lines of evidence converge towards the conclusion
that oligomeric forms of the Alzheimer amyloid peptides
(Ab) play key roles in initiating synapse dysfunction and neu-
ral death early in the disease [1–4]. The ﬁrst 16 residues of Ab
are rich in charged residues and the rest of the sequence
contains two stretches of hydrophobic residues (17–21) and
(30–40), believed to be key for oligomerization, separated by
a region containing two acidic residues (Glu 22 and Asp 23)
and a basic one (Lys 28) (Table 1). Ab oligomerization is
highly pH dependent. Precipitation and amyloid formation
are most eﬃcient at pH 5, near Ab s isoelectric point [5]. This
pH dependence could arise if the oligomers were stabilized by
speciﬁc charge–charge interactions between imidizoliumAbbreviations: Ab, the human Alzheimer Ab peptide (residues 1–40)
associated with Alzhiemers disease; EM, electron microscopy; NMR,
nuclear magnetic resonance
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doi:10.1016/j.febslet.2005.05.036groups on His residues and carboxylate groups on Asp and
Glu residues as postulated in structural models [6–8]. These
models succeed in accounting for the pH dependence of Ab
oligomerization, since these speciﬁc charge–charge interactions
are lost above pH 7, where His residues titrate and lose their
positive charge, or below pH 4, as carboxylate groups acquire
a proton and become neutral.
In contrast, other results suggest that speciﬁc charge–
charge interactions are not essential for Ab oligomerization.
The pioneering study of Fraser et al. [9] showed that short
peptide fragments of Ab carrying charge-reversal substitu-
tions (i.e., His to Asp and Asp to Lys) could oligomerize.
The central hydrophobic region of Ab adopts extended
backbone conformations similar to those detected in Ab
amyloid [10], at both acidic (pH 2.5) [11] and neutral to
mildly alkaline solution [12–14] conditions, where charged
imidiazolium–carboxylate interactions are not possible.
Moreover, the antibody that recognizes and neutralizes the
potent neurotoxic action of soluble Ab peptide oligomers
formed at neutral pH also binds oligomers formed at low
pH [15], which suggests that both neutral and low pH olig-
omers share a structural motif key for neurotoxicity that can
not be stabilized by charge–charge interactions between Asp,
Glu and His residues. These observations suggest that the
pH dependence of Ab oligomerization could be caused by
charge–charge repulsion between Ab molecules at pH values
higher or lower than its isoelectric point, and have stimu-
lated a reexamination of our previous results where salt-in-
duced changes in Ab oligomerization were attributed to
screening of intermolecular salt bridges [16].
The main purpose of this paper is to test if the pH depen-
dence of Ab oligomerization is caused by either electrostatic
repulsion between Ab molecules or speciﬁc charge–charge
interactions between carboxylate groups and histidine resi-
dues. We have designed and synthesized three Ab variants
in which all the Asp, Glu and His residues are replaced by
Ala (Table 1). Oligomerization was monitored by: (a) ThT
ﬂuorescence, which can detect small oligomers, (b) turbidity,
which reveals only very large oligomers, and (c) electron
microscopy (EM) to observe the presence of amyloid ﬁbrils.
If Ab40 oligomerization were caused by charge–charge inter-
actions between Asp, Glu and His residues, we expect that the
variants will not oligomerize. In contrast, the eﬃciency of
oligomerization is expected to show a strong negative correla-
tion with net charge if the role played by charged residues is
to generate electrostatic repulsion between Ab molecules.blished by Elsevier B.V. All rights reserved.
Table 1






+DAEFR HDSGY EVHHQ KLVFF AEDVG SNKGA IIGLM VGGVV- 5.3 
Asp Ala +AAEFR HASGY EVHHQ KLVFF AEAVG SNKGA IIGLM VGGVV- 7.1 
Glu Ala +DAAFR HDSGY AVHHQ KLVFF AADVG SNKGA IIGLM VGGVV-CONH2 8.3 
His Ala +DAEFR ADSGY EVAAQ KLVFF AEDVG SNKGA IIGLM VGGVV- 4.3 
aTerminal charges and residues bearing a positive charge or negative charge at pH 6 are colored blue or red, respectively.
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2.1. Peptide design
The sequence of Ab and three variants designed to test the role of
charge–charge interactions in oligomerization are shown in Table 1.
The C-terminus of the Gluﬁ Ala variant was amidated to remove the
charge of its carboxylate group. No charge substitution variants were
made for Lys and Arg residues, whose sidechains remain charged below
pH9, and are therefore unlikely to account for the pHdependence of Ab
oligomerization. The peptides were synthesized as previously described
[17]. Wild type and Hisﬁ Ala peptides were stored in 30 mM ammo-
nium hydroxide (pH 9.8) solution at 5 C until use, while Gluﬁ Ala
and Aspﬁ Ala peptides were stored in 30 mM acetic acid (pH 2.0).
Peptide concentrations were determined using a Bradford assay [18].
2.2. Turbidity assay for peptide aggregation
Stock peptides were diluted to 20 lM concentration using buﬀer
(1 mM borate, 1 mM citrate and 1 mM phosphate) that had been ad-
justed to the appropriate pH, and incubated 18 h at room temperature
at which point the pH of the peptide solutions were recorded. Thereaf-
ter, the apparent absorbance at 320 nm, which is proportional to the
turbidity of the solution was measured. The data for each peptide were
normalized by dividing by the maximum value (typically 0.15 absor-
bance unit) observed over the whole pH range measured.
2.3. Thioﬂavin T assay for peptide oligomerization
After completion of the turbidity measurements, concentrated ThT
was diluted into the peptide solutions to a ﬁnal concentration of
20 lM. After 15 min incubation at room temperature, ThT ﬂuores-
cence spectra were obtained using excitation wavelength of 430 nm,
2 nm slit width, 2 mm excitation path length, and 1 cm emission path
length, and quantiﬁed as previously described [5].
2.4. Calculation of net charge vs. pH
The fraction of the charged form of each ionizable group at a partic-
ular pH value was calculated using the Henderson–Hasselbach equa-
tion and the following pKa values: C-terminal, 3.8; Asp, 4.0; Glu,
4.4; His, 6.3; N-terminus, 7.5; Tyr, 9.9; Lys, 10.5; Arg, 12.5 [19]. These
charges were then summed to calculate the total net charge on the pep-
tide. The pKa values of Ma et al. [20] measured for Ab(1–28) in H2O
gave very similar proﬁles of net charge vs. pH. The correlation of
net charge with oligomerization was calculated using the paired Stu-
dent t test implemented in Kaleidagraph 3.6 (Synergy Software).
2.5. Electron microscopy
Analysis by EM was previously described [21]. In brief, negatively
stained peptide aggregateswere prepared by ﬂoating charged pioloform,
carbon-coated grids on peptide solutions. To control pH, the peptide
solutions were made using a buﬀer of 1 mM borate, 1 mM citrate and
1 mMphosphate. After the grids were blotted and air-dried, the samples
were stained with 1% (w/v) phosphotungstic acid. The Hitachi H-7000
instrument used for visualization was operated at 75 kV. The samples
were inspected and images of representative ﬁbrils were recorded.3. Results and discussion
The oligomerization of Ab and its charge substitution vari-
ants, as monitored by thioﬂavin T ﬂuorescence are shown inFig. 1. Strong increases in ﬂuorescence emission, indicative
of the formation of octamers and larger oligomers [5] were ob-
served for all the peptides (Fig. 1A). All peptides were also
capable of forming very large oligomers, as detected by turbid-
ity. This means that speciﬁc charge–charge interactions be-
tween carboxylate groups and histidine residues are not
essential for Ab oligomer formation. For each peptide, there
is a remarkable increase in oligomer formation where the net
charge is close to zero (Fig. 1B–E). When examined statisti-
cally, a very strong negative correlation (R = 0.87) was found
between the net charge and ThT monitored oligomerization
(Fig. 2). A moderately strong negative correlation (R =
0.68) was obtained for net charge vs. turbidity. On the basis
of these results, it can be deduced that rather than forming
attractive interactions that drive amyloid formation, the main
eﬀect of charge/charge interactions is to restrict Ab oligomeri-
zation to pH values where electrostatic repulsion is minimal.
The stronger relationship between ThT-detected oligomeriza-
tion and net charge suggests that electrostatic repulsion
between Ab molecules is especially crucial in preventing the
formation of small oligomers from monomer.
The ability of the peptides to form amyloid ﬁbrils was
monitored by EM (Fig. 3). The success of all the peptides to
form amyloid ﬁbrils corroborates the idea that charge–charge
interactions are not an essential requirement for Ab oligomer-
ization or amyloid formation. While there are minor morpho-
logical diﬀerences between the wild type and mutant ﬁbrils,
they all have amyloid characteristics: unbranched rigid ﬁbers
10 nm in diameter [6,7].
Our conclusions are consistent with genetic studies of familial
Alzheimers disease; four mutations (Iowa Asp23ﬁ Asn;
Arctic Glu22ﬁ Gly; Dutch Glu22ﬁ Gln, and Italian
Glu22ﬁ Lys) all decrease the Ab peptides net charge at phys-
iological pH. In contrast, if speciﬁc charge–charge interactions
involving Glu22 and Asp23 were essential for Ab oligomeriza-
tion, then their substitution by positively charged or neutral
residues should have blocked the capacity of these peptides to
oligomerize and cause disease. Similar but more general ﬁnd-
ings were obtained from a non-biased screen for mutations in
Ab that reduce its aggregation [22], which yielded many substi-
tutions that disrupt the hydrophobic interactions of the central
and C-terminal nonpolar regions, but very few charge to
neutral substitutions, as would be expected if favorable
charge–charge interactions were key to amyloid formation.
It is important to bear in mind that the speciﬁc charge–
charge interactions previously postulated [6–8] could not be ex-
cluded on the basis of the results presented here; they could
well be present in wild type Ab even though they are nonessen-
tial for oligomerization/ﬁbrillization processes. In fact, recent
nuclear magnetic resonance (NMR) structural studies have ob-
tained convincing evidence for charged Asp–His interactions
Fig. 1. The oligomerization of Ab and its variants depends strongly on net charge. Panel A. Fibrillar states of WT Ab40 (black), Aspﬁ Ala (red),
Gluﬁ Ala (green), and Hisﬁ Ala (blue) were obtained by incubation of the peptides at pH 5.5, 7.6, 8.5, and 5.0, respectively, and are represented as
ﬁlled circles. Nonﬁbrillar states of WT Ab40 (black), Aspﬁ Ala (red), Gluﬁ Ala (green), and Hisﬁ Ala (blue) were obtained by incubation of the
peptides at pH 2.5, and are represented as open circles. Panels B–E show the pH dependence of Ab oligomerization. The values of normalized ThT
ﬂuorescence (red circles) and normalized turbidity (green diamonds) are plotted using the left y-axis. Meanwhile, the absolute value of the net charge
(small black circles) is plotted using the right y-axis. Panel B. WT Ab40. Panel C. Aspﬁ Ala. Panel D. Gluﬁ Ala. Panel E. Hisﬁ Ala. The error
bars (±4%) in the normalized ThT ﬂuorescence represent the experimental reproducibility, whose main limitation is pipetting error. The uncertainties
in pH (±0.03 pH units) and normalized turbidity (±0.006, propagated from an uncertainty of ±0.001 in the apparent absorbance at 320 nm) are
smaller than the symbols shown.
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linking Glu 22 and Asp 23 to Lys 16 and Lys 28, respectively,
in amyloid ﬁbrils [10]. Recent proline-scanning studies indicate
that these interactions are not required for Ab oligomerization,toxicity and ﬁbril formation [23]. Rather than directing or sta-
bilizing amyloid ﬁbril formation, these interactions could serve
to avoid the unfavorable burial of an uncompensated charge in
a hydrophobic milieu.
Fig. 2. Correlation analysis for WT Ab peptide and variants. (A) The
absolute value of the net charge vs. normalized ThT ﬂuorescence. (B)
The absolute value of the net charge vs. normalized turbidity.
Fig. 3. Electron micrographs of amyloid ﬁbrils formed by Ab and
variants. Bar = 100 nM. (A) WT Ab. (B) Aspﬁ Ala. (C) Gluﬁ Ala.
(D) Hisﬁ Ala.
M. Guo et al. / FEBS Letters 579 (2005) 3574–3578 3577Our results show that formation of favorable charge–charge
interactions is not essential for Ab oligomerization. This is in
line with previous results [24,25] demonstrating that other clas-
ses of stabilizing interactions; namely, hydrophobic interac-
tions and hydrogen bonds, are chieﬂy responsible for
stabilizing Ab oligomers relative to monomers. These interac-
tions must overcome the unfavorable entropy changes that
accompany oligomerization [26,27]. The relative importance
of hydrogen bonds and hydrophobic interactions in Ab oligo-
merization has been elegantly demonstrated by the develop-
ment of short peptide analogues capable of impeding the
formation of intermolecular hydrogen bonds [28–31] or hydro-
phobic interactions in full-length Ab [32].
Results on other polypeptides also provide compelling
evidence that repulsive electrostatic interactions can prevent
aggregation and amyloid formation. For example, Wang
and Hecht [33] found that the substitution of a non-charged
residue by Lys in an amyloid-forming polypeptide caused it
to adopt a monomeric b-sheet structure. Moreover, for a
series of Ribonuclease Sa variants carrying charge-reversal
mutations, the ability to remain soluble as a function of
pH was found to be strictly correlated with net charge
[34]. A high net charge has been identiﬁed as an important
factor in preventing protein aggregation in vitro [35] and
in vivo [36].
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